Alternatives to HealthHub

$114 is the lowest semaglutide figure on this page, and it comes with a condition SurpassMD prints only in its FAQ: the price applies "for eligible patients with a promotion". The standing rate is published nowhere, which makes budgeting past the first cycle guesswork. What is solid: all fifty states plus DC, 503A compounding, cold-chain shipping within 48 hours of approval, HSA and FSA accepted, cancel anytime. There is an oral semaglutide as well, with no price attached.

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and the compounding pharmacy isn't named.

The arithmetic that stands out: tirzepatide costs the same as semaglutide here, both from $169 a month, where the dual agonist normally carries a $50 to $100 premium. Over a year that is a real difference. Lighter You also names four compounding pharmacies outright — RedRock, Health Warehouse, Precision Compounding and Triad Rx — with websites, addresses and phone numbers, where most of this roster names none. All fifty states plus Washington, D.C.

If injections are the blocker, this is the one to look at: DoctorAdam sells GLP-1s only as daily oral tablets, with no injectable in the catalog at all. Semaglutide tablets from $129 a month, tirzepatide tablets from $199, all fifty states, flat monthly pricing with no hidden fees. It also names its clinicians and publishes an Anaheim address. One caution when reading the grid: NAD+ injections carry the same $129 and sit near the semaglutide card.

Three clear prices — $150, $240, and $150 for an oral liposomal semaglutide — attached to statistics that do not survive checking. The "94.6% success rate" is footnoted to "approximately 66,260 Remedy Meds members", the white-label platform this site runs on rather than its own patients; a second footnote says 50,000. The live review widget reads six reviews, one member, beneath "1M+ Users on GLP-1".

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.

A granular GLP-1 menu — microdose from $129/mo, semaglutide from $149/mo, tirzepatide from $249/mo, plus an exclusive combined 'GLP-Squared' injection — all stated as all-inclusive, though the site doesn't itemize exactly what that covers.

There is no way to price Believe without applying to it. Its three GLP-1 treatment pages were read end to end and carry no dollar figure at all; the only number on the homepage is a badge promising nothing is charged if you are not approved. Behind the eligibility gate the menu is four plans, each flat at every dose: semaglutide $149 a month against a struck-through $249, tirzepatide $229 against $299 and marked most chosen, a microdose at $199, and a daily oral at $229. Those are competitive figures with two complications. The microdose costs $50 a month more than standard semaglutide, the reverse of what a lower dose implies. And two of the four plans never name a molecule, so you would be choosing between products without being told which drug is in them. It claims fifty-state care without listing states, names no pharmacy, and publishes no time to first dose.

The homepage and the pricing page tell different stories, and the pricing page is the kinder one. Every figure on the homepage carries the words "with annual prepay" — semaglutide starting at $169 a month, tirzepatide at $214 — which reads as though a year up front is the only way in. Open the full pricing table and each program has four tiers, the first labeled "Monthly · No commitment": semaglutide is $199 a month with nothing prepaid, tirzepatide $249. The prepay tiers are real savings rather than a gate — $2,028 buys a year of semaglutide at an effective $169. Everything is inside the figure: clinician evaluation, prescription, medication and shipping, with no separate consult fee. Nothing is charged unless a clinician prescribes; the card is authorized at intake as a hold, and if you are not prescribed you pay nothing. Review is typically within five hours and shipping three to five days. Coverage is 48 states plus DC, with Alaska and Mississippi named as the exclusions.